HYDI Hydromer Inc.

Hydromer Inc. Announces the Addition of Michael Torti as Vice President of Sales, Marketing and Business Development

Hydromer Inc. Announces the Addition of Michael Torti as Vice President of Sales, Marketing and Business Development

Concord, NC, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Mr. Michael Torti has vast experience in B2B sales and marketing of complex manufactured goods and medical devices and as of January 9th, 2023 has joined the Hydromer team in the capacity of Vice President of Global Sales, Marketing and Business Development

via  – Hydromer (OTC: HYDI), a world-wide supplier of specialty coatings and biopolymers for medical devices and industrial applications, announced today that Mr. Michael Torti has joined the Hydromer leadership team in the position of Vice President of Sales, Marketing and Business Development.   

Mr. Michael Torti has vast experience in B2B sales and marketing of complex manufactured goods and medical devices and as of January 9th, 2023 has joined the Hydromer team in the capacity of Vice President of Global Sales, Marketing and Business Development - reporting directly to Mr. Peter M. von Dyck, Chief Executive Officer.

Mr. Torti is a performance-driven business leader with strong sales, market development, revenue growth and company leadership skills - with over thirty years of experience.  Mike began his career as a Field Sales Engineer, covering a multi-state territory for a global manufacturing company. Through strong performance, he rose through the ranks with positions of increasing scope and management responsibility. He possesses decades of experience in the manufacturing sector, serving companies of all sizes.

His corporate background includes positions as the Managing Director (Repi LLC), Vice President – Sales and Marketing (Lexington Precision Corporation), Director of Sales, North America (Nypro Healthcare), President (Rondo-Pak), Group Vice President – CMO (Applied Tech Products, Inc.), and Director of Sales (Dynacast, Inc.).

Michael’s academic background includes a Bachelor of Science Degree in Management from the State University of New York at Binghamton.  He also received additional professional development in schools such as Warwick School (Coventry, England).

“With his extensive sales and market development skills, in addition to his deep technical knowledge and considerable track record of driving revenue growth, we feel that Michael is a wonderful addition to our Leadership Team to drive sales and help Hydromer expand its presence in the growing medical device and industrial surface modification marketplace,” said Peter M. von Dyck, Hydromer CEO.

About Hydromer®

Hydromer®, Inc & Subsidiary (the “Company”) is an ISO 9001:2015 global business-to-business (B2B) surface modification and coating solutions provider offering polymer research & development, and manufacturing services capabilities for a wide variety of applications. We are a U.S. public corporation domiciled in Concord, NC. Our customers are located across the United States of America, Europe, and Asia-Pacific. The Company was established in 1980, originally incorporated in the State of New Jersey. We are a U.S. Food and Drug Administration (FDA), Good Manufacturing Practice (GMP), International Organization for Standardization (ISO) 13485, and International Organization for Standardization (ISO) 9001 production facility. For over four decades, the Company has developed value-added solutions to serve businesses in domestic and international markets, in a wide range of industries. We manage numerous global B2B services such as, coating services, research and development, analytical testing, technology transfer, and dedicated machinery building, installation, and support. We have successfully developed numerous proprietary formulations and secured many patents worldwide at separate times throughout our history including, anti-microbial, anti-fog, anti-frost, condensation-controlling, hydrophilic and thromboresistant coatings. 





Attachment



EN
11/01/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Hydromer Inc.

 PRESS RELEASE

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Thi...

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024 CONCORD, N.C., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain preliminary, unaudited management-prepared financial results for the quarter ended September 30, 2024. These results are based on the most current information available to management, are unaudited, and are subject to the completion of the Company’s 2024 year-end ...

 PRESS RELEASE

Hydromer, Inc. Announces the Restructuring and Formation of World-Clas...

Hydromer, Inc. Announces the Restructuring and Formation of World-Class Research and Development Division to Drive Innovation and New Product Development ·       Company introduces a top-tier team of chemists to lead innovation in hydrophilic coatings and develop cutting-edge, environmentally friendly solutions ·       Restructured R&D division, under new leadership, aims to enhance product offerings, improve operational efficiency, and drive future growth CONCORD, N.C. , Oct. 21, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI), a leader in hydrophilic coating technologie...

 PRESS RELEASE

Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Fin...

Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update CONCORD, NC, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain Corporate Highlights and preliminary, unaudited management-prepared financial results for the quarter ended June 30, 2024. These results are based on the most current information available to management, are unaudited and are subject to ch...

 PRESS RELEASE

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Fir...

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 CONCORD, NC, April 29, 2024 (GLOBE NEWSWIRE) -- via -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain preliminary, unaudited management-prepared financial results for the quarter ended March 31, 2024. These results are based on the most current information available to management, are unaudited, and are subject to the completion of the Company’s 2024 year-en...

 PRESS RELEASE

Hydromer, Inc. Wraps Up a Successful 2023, Including Restructuring, Co...

Hydromer, Inc. Wraps Up a Successful 2023, Including Restructuring, Contract Extensions, and the Launch of New Innovations CONCORD, NC, Jan. 16, 2024 (GLOBE NEWSWIRE) -- via – Hydromer, Inc. (OTC: HYDI) Hydromer, Inc. (the “Company”) is pleased to provide the following update to shareholders regarding the Company’s progress toward stability and profitable growth. Much has been done since the spring of 2023 in reducing the Company’s overhead and operating costs, which management believes will lead to improved profitability in the current fiscal year. Additionally, investment in new prod...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch